Ian Douglas Pavord (Ian D Pavord, Ian Pavord)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 60

Top Venues

Allergy

Thorax

Respirology (Carlton, Vic.)

American journal of respiratory and critical care medicine

University of Oxford

University of London (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Oxford

United Kingdom

Professor of Respiratory Medicine/Honorary Consultant Physician :: Respiratory Medicine

University of Leicester

United Kingdom

Honorary Professor :: Divison of Respiratory Medicine

Glenfield Hospital

United Kingdom

Consultant Physician :: Respiratory Medicine

McMaster University Medical Centre

Canada

Clinical Fellow to Prof FE Hargreave :: Firestone Regional Chest and Allergy Unit

City Hospital

United Kingdom

Lecturer in Respiratory Medicine (Honorary Senior Registrar) :: Respiratory Medicine Unit

Nottingham City Hospital

United Kingdom

Research Fellow in Respiratory Medicine - Professor AE Tattersfield,

Peterborough and Leicester Hospitals

United Kingdom

Medical Registrar

Taunton and Somerset Hospitals

United Kingdom

SHO Medical Rotation

Rochford Hospital

United Kingdom

House Surgeon

Chelsea and Westminster Hospital

United Kingdom

House Physician

Education History

University of London

United Kingdom

BSC

Publications

Nayia Petousi, Ian Douglas Pavord, Brian Daniel Kent
Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease. Thorax 79 (4) (2024)
Gabriel Garcia, Sven C van Dijkman, Ian Douglas Pavord, Dave Singh, Sean P Oosterholt, Sourabh Fulmali, Anurita Majumdar, Oscar Della Pasqua
A Simulation Study of the Effect of Clinical Characteristics and Treatment Choice on Reliever Medication Use, Symptom Control and Exacerbation Risk in Moderate-Severe Asthma. Advances in therapy (2024)
Nayia Petousi, Ian Douglas Pavord, Brian Daniel Kent
Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease. Thorax 79 (4) (2024)
Maisha F Jabeen, Nicholas S R Sanderson, Mariaenrica Tinè, Gillian Donachie, Clair Barber, Adnan Azim, Laurie C K Lau, Thomas P Brown, Ian Douglas Pavord, Anoop J Chauhan, Paul Klenerman, Teresa L Street, Emanuele Marchi, Peter J Howarth, Timothy Stopford Christopher Hinks
Species-level, metagenomic and proteomic analysis of microbe-immune interactions in severe asthma. Allergy (2024)
Gabriel Garcia, Sven C van Dijkman, Ian Douglas Pavord, Dave Singh, Sean P Oosterholt, Sourabh Fulmali, Anurita Majumdar, Oscar Della Pasqua
A Simulation Study of the Effect of Clinical Characteristics and Treatment Choice on Reliever Medication Use, Symptom Control and Exacerbation Risk in Moderate-Severe Asthma. Advances in therapy 41 (8) (2024)
Nayia Petousi, Ian Douglas Pavord, Brian Daniel Kent
Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease. Thorax (2024)
Lola Loewenthal, John Busby, Ronald McDowell, Thomas Brown, Hassan Burhan, Rekha Chaudhuri, Paddy Dennison, James William Dodd, Simon Doe, Shoaib Faruqi, Robin Gore, Elfatih Idris, David Joshua Jackson, Mitesh Patel, Thomas Pantin, Ian Douglas Pavord, Paul E Pfeffer, David J Price, Hitasha Rupani, Salman Siddiqui, Liam G Heaney, Andrew Menzies-Gow, null null
Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care. Thorax 79 (5) (2024)
Gabriel Garcia, Sven C van Dijkman, Ian Douglas Pavord, Dave Singh, Sean P Oosterholt, Sourabh Fulmali, Anurita Majumdar, Oscar Della Pasqua
A Simulation Study of the Effect of Clinical Characteristics and Treatment Choice on Reliever Medication Use, Symptom Control and Exacerbation Risk in Moderate-Severe Asthma. Advances in therapy 41 (8) (2024)
Gabriel Garcia, Sven C van Dijkman, Ian Douglas Pavord, Dave Singh, Sean P Oosterholt, Sourabh Fulmali, Anurita Majumdar, Oscar Della Pasqua
A Simulation Study of the Effect of Clinical Characteristics and Treatment Choice on Reliever Medication Use, Symptom Control and Exacerbation Risk in Moderate-Severe Asthma. Advances in therapy 41 (8) (2024)
Lola Loewenthal, John Busby, Ronald McDowell, Thomas Brown, Hassan Burhan, Rekha Chaudhuri, Paddy Dennison, James William Dodd, Simon Doe, Shoaib Faruqi, Robin Gore, Elfatih Idris, David Joshua Jackson, Mitesh Patel, Thomas Pantin, Ian Douglas Pavord, Paul E Pfeffer, David J Price, Hitasha Rupani, Salman Siddiqui, Liam G Heaney, Andrew Menzies-Gow, null null
Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care. Thorax 79 (5) (2024)
Sanjay Ramakrishnan, Brett Montgomery, Ian Douglas Pavord
Blood eosinophils and lung function loss: from passive prediction to active prevention? The European respiratory journal 63 (5) (2024)
Alvar Agustí, Bartolome R Celli, Gerard J Criner, David M G Halpin, Antonio Anzueto, Peter Barnes, Jean Bourbeau, MeiLan K Han, Fernando J Martinez, Maria Montes de Oca, Kevin Mortimer, Alberto Papi, Ian Douglas Pavord, Nicholas Roche, Sundeep Salvi, Don D Sin, Dave Singh, Robert Stockley, M Victorina López Varela, Jadwiga A Wedzicha, Claus F Vogelmeier
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Respirology (Carlton, Vic.) (2023)
Marta Wanat, Carol Stonham, Christine Rutherford, Ian Douglas Pavord
Fractional exhaled nitric oxide (FeNO): the future of asthma care? The British journal of general practice : the journal of the Royal College of General Practitioners 73 (737) (2023)
William Walter Busse, Ian Douglas Pavord, Shahid Siddiqui, Asif Hameed Khan, Amy Praestgaard, Scott Nash, Juby Anne Jacob-Nara, Paul Jonathan Rowe, Yamo Deniz
Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics. Journal of asthma and allergy 16 (2023)
Klaus Friedrich Rabe, Ian Douglas Pavord, William Walter Busse, Geoffrey L Chupp, Kenji Izuhara, Arman Altincatal, Rebecca Gall, Nami Pandit-Abid, Yamo Deniz, Paul J Rowe, Juby A Jacob-Nara, Amr Radwan
Dupilumab Improves Long-term Outcomes in Patients With Uncontrolled, Moderate-to-Severe GINA-Based Type 2 Asthma, Irrespective of Allergic Status. Allergy (2023)
William Walter Busse, Ian Douglas Pavord, Shahid Siddiqui, Asif Hameed Khan, Amy Praestgaard, Scott Nash, Juby Anne Jacob-Nara, Paul Jonathan Rowe, Yamo Deniz
Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics. Journal of asthma and allergy 16 (2023)
Ian Douglas Pavord, Arnaud Bourdin, Alberto Papi, Christian Domingo Ribas, Jonathan Corren, Arman Altincatal, Amr Radwan, Nami Pandit, Juby Anne Jacob-Nara, Yamo Deniz, Paul J Rowe, Elizabeth Laws, David J Lederer, Megan Hardin
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of ICS dose. Allergy (2023)
Ian Douglas Pavord
New statement and new hope for patients with refractory chronic cough. Thorax 78 (Suppl 6) (2023)
William Walter Busse, Ian Douglas Pavord, Shahid Siddiqui, Asif Hameed Khan, Amy Praestgaard, Scott Nash, Juby Anne Jacob-Nara, Paul Jonathan Rowe, Yamo Deniz
Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics. Journal of asthma and allergy 16 (2023)
Marco Caminati, Roland Buhl, Jonathan Corren, Nicola A Hanania, Harold Kim, Stephanie Korn, Marek Lommatzsch, Neil Martin, Andrea Matucci, Shuaib M Nasser, Ian Douglas Pavord, Christian Domingo
Tezepelumab in patients with allergic and eosinophilic asthma. Allergy 79 (5) (2023)
Imran Howell, Aleksandra Howell, Ian Douglas Pavord
Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight. The Journal of experimental medicine 220 (7) (2023)
Alvar Agustí, Bartolome R Celli, Gerard J Criner, David M G Halpin, Antonio Anzueto, Peter Barnes, Jean Bourbeau, MeiLan K Han, Fernando J Martinez, Maria Montes de Oca, Kevin Mortimer, Alberto Papi, Ian Douglas Pavord, Nicholas Roche, Sundeep Salvi, Don D Sin, Dave Singh, Robert Stockley, M Victorina López Varela, Jadwiga A Wedzicha, Claus F Vogelmeier
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Respirology (Carlton, Vic.) (2023)
William Walter Busse, Ian Douglas Pavord, Shahid Siddiqui, Asif Hameed Khan, Amy Praestgaard, Scott Nash, Juby Anne Jacob-Nara, Paul Jonathan Rowe, Yamo Deniz
Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics. Journal of asthma and allergy 16 (2023)
Marco Caminati, Roland Buhl, Jonathan Corren, Nicola A Hanania, Harold Kim, Stephanie Korn, Marek Lommatzsch, Neil Martin, Andrea Matucci, Shuaib M Nasser, Ian Douglas Pavord, Christian Domingo
Tezepelumab in patients with allergic and eosinophilic asthma. Allergy (2023)
Marco Caminati, Roland Buhl, Jonathan Corren, Nicola A Hanania, Harold Kim, Stephanie Korn, Marek Lommatzsch, Neil Martin, Andrea Matucci, Shuaib M Nasser, Ian Douglas Pavord, Christian Domingo
Tezepelumab in patients with allergic and eosinophilic asthma. Allergy 79 (5) (2023)
Lola Loewenthal, John Busby, Ronald McDowell, Thomas Brown, Hassan Burhan, Rekha Chaudhuri, Paddy Dennison, James William Dodd, Simon Doe, Shoaib Faruqi, Robin Gore, Elfatih Idris, David Joshua Jackson, Mitesh Patel, Thomas Pantin, Ian Douglas Pavord, Paul E Pfeffer, David J Price, Hitasha Rupani, Salman Siddiqui, Liam G Heaney, Andrew Menzies-Gow, null null
Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care. Thorax (2023)
Marco Caminati, Roland Buhl, Jonathan Corren, Nicola A Hanania, Harold Kim, Stephanie Korn, Marek Lommatzsch, Neil Martin, Andrea Matucci, Shuaib M Nasser, Ian Douglas Pavord, Christian Domingo
Tezepelumab in patients with allergic and eosinophilic asthma. Allergy 79 (5) (2023)
Imran Howell, Mahdi Mahdi, Mona Bafadhel, Timothy Stopford Christopher Hinks, Sanjay Ramakrishnan, James Melhorn, Maisha F Jabeen, Ian Douglas Pavord
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST). JMIR research protocols 12 (2023)
Gabriel Lavoie, Ian Douglas Pavord
Which biologic? New findings from a real-world study. Respirology (Carlton, Vic.) (2023)
Imran Howell, Aleksandra Howell, Ian Douglas Pavord
Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight. The Journal of experimental medicine 220 (7) (2023)
Simon Couillard, Ian Douglas Pavord, Liam G Heaney, Nayia Petousi, Timothy Stopford Christopher Hinks
Sub-stratification of type-2 high airway disease for therapeutic decision-making: A 'bomb' (blood eosinophils) meets 'magnet' (FeNO) framework. Respirology (Carlton, Vic.) 27 (8) (2022)
Liam G Heaney, John Busby, Catherine E Hanratty, Ratko Djukanović, Ashley Woodcock, Samantha Walker, Timothy Colin Hardman, Joseph R Arron, David F Choy, Peter Bradding, Christopher E Brightling, Rekha Chaudhuri, Douglas Cowan, Adel Hasan Mansur, Stephen J Fowler, Christopher E Brightling, Peter Howarth, James Lordan, Andrew N Menzies-Gow, Timothy Harrison, Douglas S Robinson, Cecile T J Holweg, John G Matthews, Ian Douglas Pavord, Liam G Heaney
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes. American journal of respiratory and critical care medicine 206 (5) (2022)
Christopher E Brightling, Koirobi Haldar, Pamela Jane McDowell, John Busby, Vijay Mistry, Claudia Micieli, Vanessa Brown, Ciara Cox, Freda Yang, Catherine Borg, Rahul Shrimanker, Mohammadali Yavari Ramsheh, Tim Hardman, Joseph Arron, Peter Bradding, Douglas Cowan, Adel Hasan Mansur, Stephen J Fowler, Jim Lordan, Andrew Menzies-Gow, Douglas Robinson, John Matthews, Ian Douglas Pavord, Rekha Chaudhuri, Liam G Heaney, Michael R Barer, Christopher Brightling, null null
Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation. Allergy 77 (11) (2022)
Juliet M Foster, Richard Beasley, Irene Braithwaite, Timothy Harrison, Mark Holliday, Ian Douglas Pavord, Helen K Reddel
Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study. BMJ open 12 (1) (2022)
Stephanie Chen, Marc Miravitlles, Chin Kook Rhee, Ian Douglas Pavord, Rupert Jones, Victoria Carter, Benjamin Emmanuel, Marianna Alacqua, David J Price
Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy. International journal of chronic obstructive pulmonary disease 17 (2022)
Dennis Thomas, Vanessa Marie McDonald, Ian Douglas Pavord, Peter Gerard Gibson
Asthma remission: what is it and how can it be achieved? The European respiratory journal 60 (5) (2022)
Alvar Agustí, Eleni Rapsomaniki, Richard Beasley, Rod Hughes, Hana Müllerová, Alberto Papi, Ian Douglas Pavord, Maarten van den Berge, Rosa Faner, null null
Treatable traits in the NOVELTY study. Respirology (Carlton, Vic.) 27 (11) (2022)
Simon Couillard, Rahul Shrimanker, Samuel Lemaire-Paquette, Gareth M Hynes, Catherine Borg, Clare Connolly, Samantha Jane Thulborn, Angela M Moran, Sarah Poole, Sophie Morgan, Timothy J Powell, Ian Douglas Pavord, Timothy Stopford Christopher Hinks
Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing. Thorax (2022)
Simon Couillard, Ian Douglas Pavord
Fluticasone furoate: CAPTAIN of fluticasones in type 2 inflammatory asthma. Respirology (Carlton, Vic.) 27 (3) (2022)
Latifa Khalfaoui, Fiona A Symon, Simon Couillard, Beverley Hargadon, Rekha Chaudhuri, Steve Bicknell, Adel Hasan Mansur, Rahul Shrimanker, Timothy Stopford Christopher Hinks, Ian Douglas Pavord, Stephen J Fowler, Vanessa Brown, Lorcan P McGarvey, Liam G Heaney, Cary D Austin, Peter H Howarth, Joseph R Arron, David F Choy, Peter Bradding
Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker-high and -low severe asthma. Allergy 77 (10) (2022)
Jonathan Youngs, Nicholas M Provine, Nicholas Lim, Hannah R Sharpe, Ali Amini, Yi-Ling Chen, Jian Luo, Matthew D Edmans, Panagiota Zacharopoulou, Wentao Chen, Oliver Sampson, Robert S Paton, William J Hurt, David A Duncan, Anna L McNaughton, Vincent N Miao, Susannah Leaver, Duncan L A Wyncoll, Jonathan Ball, Philip Hopkins, null null, null null, Donal T Skelly, Eleanor Barnes, Susanna J Dunachie, Graham Ogg, Teresa Lambe, Ian Douglas Pavord, Alex K Shalek, Craig P Thompson, Luzheng Xue, Derek C Macallan, Philip J R Goulder, Paul Klenerman, Tihana Bicanic
Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients. PLoS pathogens 17 (9) (2021)
Wentao Chen, Jian Luo, Yuan Ye, Ryan Hoyle, Wei Liu, Rowie Borst, Shamsah Kazani, Eric A Shikatani, Veit J Erpenbeck, Ian Douglas Pavord, Paul Klenerman, David A Sandham, Luzheng Xue
The Roles of Type 2 Cytotoxic T Cells in Inflammation, Tissue Remodeling, and Prostaglandin (PG) D2 Production Are Attenuated by PGD2 Receptor 2 Antagonism. Journal of immunology (Baltimore, Md. : 1950) 206 (11) (2021)
Richard Beasley, Pepa Bruce, Lee Hatter, Irene Braithwaite, Alex Semprini, Ciléin Kearns, Mark Weatherall, Ian Douglas Pavord
A Proposed Revision of the Stepwise Treatment Algorithm in Asthma. American journal of respiratory and critical care medicine 204 (1) (2021)
Simon Couillard, Rahul Shrimanker, Rekha Chaudhuri, Adel Hasan Mansur, Lorcan P McGarvey, Liam G Heaney, Stephen J Fowler, Peter Bradding, Ian Douglas Pavord, Timothy Stopford Christopher Hinks
Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma. American journal of respiratory and critical care medicine 204 (6) (2021)
Ian Douglas Pavord, Kenneth R Chapman, Mona Bafadhel, Frank C Sciurba, Eric S Bradford, Stephanie Schweiker Harris, Bhabita Mayer, David B Rubin, Steven W Yancey, Pierluigi Paggiaro
Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO. International journal of chronic obstructive pulmonary disease 16 (2021)
Ian Douglas Pavord, Elisabeth H Bel, Arnaud Bourdin, Robert Chan, Joseph K Han, Oliver N Keene, Mark C Liu, Neil Martin, Alberto Papi, Florence Roufosse, Jonathan Steinfeld, Michael E Wechsler, Steven W Yancey
From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases. Allergy (2021)
Simon Couillard, William Il Hoon Do, Richard Beasley, Timothy Stopford Christopher Hinks, Ian Douglas Pavord
Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE). ERJ open research 8 (1) (2021)
Simon Couillard, Annette Laugerud, Maisha F Jabeen, Sanjay Ramakrishnan, James Melhorn, Timothy Stopford Christopher Hinks, Ian Douglas Pavord
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide. Thorax (2021)
Rupert C Jones, Andrew Davis, Brooklyn Stanley, Steven Julious, Dermot Ryan, David J Jackson, David M G Halpin, Katherine Hickman, Hilary Pinnock, Jennifer Kathleen Quint, Kamlesh Khunti F MedSci, Liam G Heaney, Phillip Oliver, Salman Siddiqui, Ian Douglas Pavord, David H M Jones, Michael Hyland, Lewis Ritchie, Pam Young, Tony Megaw, Steve Davis, Samantha Walker, Stephen Holgate, Sue Beecroft, Anu Kemppinen, Francis Appiagyei, Emma-Jane Roberts, Megan Preston, Antony Hardjojo, Victoria Carter, Marije van Melle, David J Price
Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients. Pragmatic and observational research 12 (2021)
Richard Beasley, James Harper, Grace Bird, Ingrid Maijers, Mark Weatherall, Ian Douglas Pavord
Inhaled Corticosteroid Therapy in Adult Asthma. Time for a New Therapeutic Dose Terminology. American journal of respiratory and critical care medicine 199 (12) (2020)
Richard Beasley, James Harper, Grace Bird, Ingrid Maijers, Mark Weatherall, Ian Douglas Pavord
Reply to Boulet and Nair: Inhaled Corticosteroids and Adult Asthma. American journal of respiratory and critical care medicine 200 (12) (2020)
Richard Beasley, Irene Braithwaite, Alex Semprini, Ciléin Kearns, Mark Weatherall, Tim W Harrison, Alberto Papi, Ian Douglas Pavord
ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma. The European respiratory journal 55 (1) (2020)
Ian Douglas Pavord, Salman Siddiqui, Alberto Papi, Jonathan Corren, Lawrence D Sher, Philip Bardin, David Langton, Hae-Sim Park, Megan S Rice, Yamo Deniz, Paul Rowe, Heribert W Staudinger, Naimish Patel, Marcella Ruddy, Neil M H Graham, Ariel Teper
Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function. Journal of asthma and allergy 13 (2020)
Richard Beasley, Irene Braithwaite, Alex Semprini, Ciléin Kearns, Mark Weatherall, Ian Douglas Pavord
Optimal Asthma Control: Time for a New Target. American journal of respiratory and critical care medicine 201 (12) (2020)
J Mark FitzGerald, Peter John Barnes, Bradley E Chipps, Christine R Jenkins, Paul M O'Byrne, Ian Douglas Pavord, Helen K Reddel
The burden of exacerbations in mild asthma: a systematic review. ERJ open research 6 (3) (2020)
Ian Douglas Pavord
Blood Eosinophil-directed Management of Airway Disease. The Past, Present, and Future. American journal of respiratory and critical care medicine 202 (5) (2020)
Richard E K Russell, Ian Douglas Pavord
The Use of Inhaled Corticosteroids to Prevent Acute Exacerbations of COPD: A Pro/Con Debate. Turkish thoracic journal 20 (3) (2019)
Angela Moran, Ian Douglas Pavord
COPD exacerbation phenotypes: The next frontier. Respirology (Carlton, Vic.) 25 (3) (2019)
Timothy Stopford Christopher Hinks, Paul Batty, Paul Klenerman, Ian Douglas Pavord, Luzheng Xue
Cytometric Gating Stringency Impacts Studies of Type 2 Innate Lymphoid Cells in Asthma. American journal of respiratory cell and molecular biology 57 (6) (2018)
Ian Douglas Pavord
GLUCOLD, eosinophils and chronic obstructive pulmonary disease. Respirology (Carlton, Vic.) 23 (11) (2018)

Ian Douglas Pavord.css-eqlu8i{font-size:small;padding-left:4px;} (Ian D Pavord, Ian Pavord)

Publication Activity (10 Years)

Top Topics

Top Venues

Ian Douglas Pavord (Ian D Pavord, Ian Pavord)